Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate: Reply

Yvonne C. Lee; Jing Cui; Karen H. Costenbader; Nancy A. Shadick; Michael E. Weinblatt; Elizabeth W. Karlson

doi:10.1093/rheumatology/kep179

Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate: Reply

Yvonne C. Lee^*, Jing Cui, Karen H. Costenbader, Nancy A. Shadick, Michael E. Weinblatt, Elizabeth W. Karlson

^*Corresponding author for this work

Medicine, Rheumatology Division

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1177
Number of pages	1
Journal	Rheumatology
Volume	48
Issue number	9
DOIs	https://doi.org/10.1093/rheumatology/kep179
State	Published - Sep 2009

ASJC Scopus subject areas

Rheumatology
Pharmacology (medical)

Access to Document

10.1093/rheumatology/kep179

Cite this

@article{99053972ecfc48bb81197f3fb8b72802,

title = "Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate: Reply",

author = "Lee, {Yvonne C.} and Jing Cui and Costenbader, {Karen H.} and Shadick, {Nancy A.} and Weinblatt, {Michael E.} and Karlson, {Elizabeth W.}",

note = "Funding Information: Disclosure statement: M.E.W. has received grant support funding for the BRASS Registry from Biogen Idec and Cresendo and is a consultant for Crescendo, Biogen Idec and Cypress Pharmaceuticals. N.A.S. has received grant support from Crescendo, Biogen Idec, Amgen and Bristol-Myers Squibb Foundation. All other authors have declared no conflicts of interest.",

year = "2009",

month = sep,

doi = "10.1093/rheumatology/kep179",

language = "English (US)",

volume = "48",

pages = "1177",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Comment on

T2 - Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate: Reply

AU - Lee, Yvonne C.

AU - Cui, Jing

AU - Costenbader, Karen H.

AU - Shadick, Nancy A.

AU - Weinblatt, Michael E.

AU - Karlson, Elizabeth W.

N1 - Funding Information: Disclosure statement: M.E.W. has received grant support funding for the BRASS Registry from Biogen Idec and Cresendo and is a consultant for Crescendo, Biogen Idec and Cypress Pharmaceuticals. N.A.S. has received grant support from Crescendo, Biogen Idec, Amgen and Bristol-Myers Squibb Foundation. All other authors have declared no conflicts of interest.

PY - 2009/9

Y1 - 2009/9

UR - http://www.scopus.com/inward/record.url?scp=77955822361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955822361&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kep179

DO - 10.1093/rheumatology/kep179

M3 - Letter

AN - SCOPUS:77955822361

SN - 1462-0324

VL - 48

SP - 1177

JO - Rheumatology

JF - Rheumatology

IS - 9

ER -

Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate: Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this